Combining donepezil and memantine extends lives of Alzheimer’s patients, study finds

FHS
June 13, 2024
3:52 am

Alzheimer’s disease is the world’s most common neurodegenerative disease, affecting more than 50 million people globally.

Otsuka wins FDA breakthrough therapy designation for IgAN drug – Pharmaceutical Technology

Share this article The FDA has granted breakthrough therapy designation following positive Phase II data released in November. Credit: grandbrothers via Shutterstock. After a high-profile

February 16, 2024

ProMED sees offers of support, but its future remains unclear

With its future in doubt, ProMED, the financially strapped infectious diseases surveillance network, has seen waves of support pour in in recent weeks, with universities

August 18, 2023

Rescue from above: How drones may narrow emergency response times

The drones are coming. Starting in September, if someone in Clemmons, North Carolina, calls 911 to report a cardiac arrest, the first responder on the

July 22, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.